Stock 603439 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company GuiZhou SanLi Pharmaceutical Co.,Ltd

Equities

603439

CNE1000040B4

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
15.79 CNY +0.13% Intraday chart for GuiZhou SanLi Pharmaceutical Co.,Ltd -0.25% -16.37%
04-26 Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Guizhou Sanli Pharmaceutical Co Ltd is a company mainly engaged in the research and development, production and sales of Chinese patent medicines. The Company's product lines cover various areas, including pediatrics, respiratory systems, cardio-cerebrovascular and gastroenterology. Its main products are Kaihoujian spray (Pediatric Use), Kaihoujian spray and Qiangli Gastrodia Elata Eucommia capsules. The Kaihoujian spray (Pediatric Use) and Kaihoujian spray are used for the treatment of respiratory and oral diseases, and the Qiangli Gastrodia Elata Eucommia capsule is used for the treatment of cardiovascular and cerebrovascular diseases. The Company mainly sells its products through specialized academic marketing.

Number of employees: 1,557

Sales per Business

CNY in Million2022Weight2023Weight Delta
Respiratory System Medications
79.5 %
- - 1,300 79.5 % -
Blood Medications
6.9 %
- - 112 6.9 % -
Gynecological Medications
4.7 %
43 3.6 % 77 4.7 % +79.81%
Tonic Medicine
2.8 %
- - 46 2.8 % -
Cardiovascular and Cerebrovascular Drugs
2.5 %
- - 41 2.5 % -
Orthopedic Medication
2.2 %
- - 35 2.2 % -
Other
1.3 %
53 4.4 % 22 1.3 % -59.40%
Other Business
0.0 %
0 0.0 % 1 0.0 % +53.42%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,201 100.0 % 1,635 100.0 % +36.10%

Managers

Managers TitleAgeSince
Hai Zhang CEO
 Chief Executive Officer 39 31/12/07
Hong Yu Zhang DFI
 Director of Finance/CFO 61 31/08/13
Qian Fan Zhang BRD
 Director/Board Member 39 30/09/14
Kuan Yu Liu IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Shi Gui Chen BRD
 Director/Board Member 61 11/12/22
Qiang Wang BRD
 Director/Board Member 54 11/12/22
Hai Zhang CEO
 Chief Executive Officer 39 31/12/07
Hong Yu Zhang DFI
 Director of Finance/CFO 61 31/08/13
Qian Fan Zhang BRD
 Director/Board Member 39 30/09/14
Yong Jian Sheng BRD
 Director/Board Member 50 31/08/11
Jing Long CHM
 Chairman 39 28/02/11
Yi Yang BRD
 Director/Board Member 31 31/12/15
Dong Gui BRD
 Director/Board Member 50 11/12/22
Dong Hai Liang BRD
 Director/Board Member 41 22/11/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 409,862,216 166,053,510 ( 40.51 %) 5,090,900 ( 1.242 %) 40.51 %

Shareholders

NameEquities%Valuation
Hai Zhang
46.20 %
188,668,440 46.20 % 408 M ¥
Hui Ying Wang
5.718 %
23,347,947 5.718 % 50 M ¥
Yong Jian Sheng
5.369 %
21,924,559 5.369 % 47 M ¥
Shanghai Guosheng Capital Management Co., Ltd.
5.020 %
20,500,000 5.020 % 44 M ¥
Zhong Ou Asset Management Co., Ltd
1.530 %
6,246,000 1.530 % 14 M ¥
Shu Yu Yang
1.094 %
4,465,700 1.094 % 10 M ¥
AXA-SPDB Investment Managers Co., Ltd.
0.9886 %
4,036,800 0.9886 % 9 M ¥
Tianjin Zhonghe Yida Investment LLC
0.4627 %
1,889,400 0.4627 % 4 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
0.4255 %
1,737,600 0.4255 % 4 M ¥
Min Chen
0.3692 %
1,507,600 0.3692 % 3 M ¥

Company contact information

GuiZhou SanLi Pharmaceutical Co., Ltd.

Xiayun Industrial Park Pingba District

561100, Anshun

+

http://www.gz-sanli.com
address GuiZhou SanLi Pharmaceutical Co.,Ltd(603439)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for GuiZhou SanLi Pharmaceutical Co.,Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.79 CNY
Average target price
19.84 CNY
Spread / Average Target
+25.65%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
GUIZHOU SANLI PHARMACEUTICAL CO.,LTD Stock GuiZhou SanLi Pharmaceutical Co.,Ltd
-16.37% 893M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 603439 Stock
  4. Company GuiZhou SanLi Pharmaceutical Co.,Ltd